The mTOR pathway, a known inducer of senescence, displays increased activation in patients with COPD relative to controls, and in vitro inhibition of the pathway with rapamycin decreased cellular senescence in pulmonary endothelial and smooth muscle cells from patients with COPD (Houssaini et al., 2018). This evidence concerns the gene MTOR and chronic obstructive pulmonary disease.